Pathway Financial Advisers’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-255
Closed -$9.69K 237
2024
Q4
$9.69K Buy
255
+1
+0.4% +$45 ﹤0.01% 360
2024
Q3
$12.7K Buy
254
+1
+0.4% +$45 0.01% 283
2024
Q2
$12.3K Buy
253
+1
+0.4% +$50 ﹤0.01% 329
2024
Q1
$11.9K Buy
252
+1
+0.4% +$40 ﹤0.01% 333
2023
Q4
$10.7K Buy
251
+1
+0.4% +$37 ﹤0.01% 356
2023
Q3
$9.32K Buy
+250
New +$10.1K ﹤0.01% 368
2023
Q1
Sell
-166
Closed -$6.29K 517
2022
Q4
$6.29K Buy
+166
New +$5.8K ﹤0.01% 472

Other funds holding FCX

Pathway Financial Advisers's FCX Position: Q1 2025 in Review

Pathway Financial Advisers sold out of Freeport-McMoran (FCX) in Q1 2025, closing a stake of 255 shares — an estimated $9.69K sold.

Pathway Financial Advisers first reported a position in FCX in Q4 2022 and held it in 7 quarters. The position peaked at $12.7K in Q3 2024. 1,449 funds tracked by Wall St. Rank hold FCX as of Q1 2025.

  • Pathway Financial Advisers reported no remaining Freeport-McMoran position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 255 Freeport-McMoran shares in Q1 2025, an estimated $9.69K.
  • Pathway Financial Advisers first reported a position in Freeport-McMoran in Q4 2022 and held it in 7 quarters.
  • Pathway Financial Advisers's Freeport-McMoran position peaked at $12.7K in Q3 2024.
  • 1,449 funds tracked by Wall St. Rank held Freeport-McMoran as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.